Welcome to the Department of Uro-Oncology at Sterling Hospital Rajkot, We are proud to offer comprehensive and advanced care for all types of urological cancers under one roof. Our dedicated team of specialists includes surgical oncologists, medical oncologists, radiation oncologists, and urologists who work together to provide personalized and patient-centric care. 

Our state-of-the-art facilities are equipped with the latest technology to ensure accurate diagnosis and effective treatment of urological cancers. Our advanced diagnostic facilities include: 

• CT scan 

• MRI 

• PSMA Pet Scan 

These provide precise imaging of the affected area for accurate diagnosis. 

Our team of experts offers advanced surgical care for urological cancers, including: 

• Open 

• Laparoscopic 

• Robotic (minimally-invasive) procedures 

Our surgical team is highly experienced and ensures that each patient receives the best possible surgical care. 

Our department also has a team of medical oncologists who specialize in the treatment of urological cancers. They use the latest treatment options, including: 

• Chemotherapy 

• Immunotherapy 

• Targeted therapy 

To provide the best possible outcome for our patients. 

Radiation therapy is a critical part of urological cancer treatment protocol. Our radiation machine (True beam STx SVC linac) is the most advanced machine with 6D couch enabling advanced techniques like IMRT, IGRT, SRS, SBRT/SABR with utmost precision and accurate tumor targeting. Our experienced team of radiation oncologists ensure precise tumour motion tracking to reduce radiation to normal healthy tissues. 

At our department, we believe that each patient is unique, and we provide personalized care to meet their individual needs. We strive to make the patient feel comfortable and supported throughout their treatment journey. 

If you or a loved one has been diagnosed with urological cancer, we are here to help. Contact us to schedule a consultation with one of our experts and learn more about the advanced care we offer at our hospital. 

We offer a variety of treatment options for urological cancers, including surgery, radiation therapy, chemotherapy, and immunotherapy. We also offer support services to help patients cope with the emotional and physical challenges of cancer treatment.

Uro Oncology Care at Sterling Hospitals Rajkot,     

At Sterling Hospitals Rajkot,  , we provide comprehensive and personalized care for urological cancers with the help of our multidisciplinary team of surgical oncologists, robotic surgeons, medical oncologists, and radiation oncologists. Our team of specialists uses the latest technologies and advanced protocols for the diagnosis and treatment of urological cancers.  

Our uro-oncology department is equipped with state-of-the-art facilities to provide safe and precise treatments like minimally-invasive surgeries, robot-assisted surgeries, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. We ensure patient-centric and personalized care for all our patients.  

Our treatment services include:  

• Radical prostatectomy and pelvic lymphadenectomy for prostate cancer – Open/Laparoscopic/Robotic  

• Partial nephrectomy/nephron-sparing surgery and nephroureterectomy for kidney cancers and urothelial carcinoma of the kidney and ureter - Open/Laparoscopic/Robotic  

• Radical cystectomy and reconstruction procedures like ileal conduit/neobladder reconstruction for bladder cancers - Open/Laparoscopic/Robotic  

• Adrenalectomy for benign tumours and cancers of the adrenal gland  

• Retroperitoneal lymphadenectomy for testicular cancers  

• Inguinal lymphadenectomy for penile cancers  

• Salvage surgical procedures  

• High-dose and low-dose chemotherapy  

• Hormone therapy for prostate cancer  

• Immunotherapy and targeted therapy for metastatic urological cancers  

• Targeted external beam radiation therapy  

We are committed to providing our patients with the best possible care and support throughout their treatment journey. If you or a loved one has been diagnosed with urological cancer, contact us to schedule a consultation with one of our expert uro-oncologists.  

  Services procedures   

• Radical Prostatectomy  

• Nephrectomy  

• Chemotherapy   

• Hormone Therapy  

• Targeted & Immunotherapy  

• Radiotherapy  

Radical prostatectomy  

Radical prostatectomy is a surgical procedure performed to remove the prostate gland, which is a walnut-sized gland located below the bladder in men. It is commonly used as a treatment option for localized prostate cancer, where the cancer is confined to the prostate gland and has not spread to other parts of the body. Radical prostatectomy aims to remove the entire prostate gland along with nearby lymph nodes, if necessary, to effectively treat the cancer  

Indications for Radical Prostatectomy at Sterling Hospitals Rajkot,  :  

• Prostate cancer: Radical prostatectomy is a common treatment option for localized prostate cancer, where the cancer is confined to the prostate gland and has not spread to other parts of the body.  

• High-risk prostate cancer: Radical prostatectomy may be recommended for patients with high-risk prostate cancer, which includes aggressive or advanced tumors, based on the evaluation of various factors such as Gleason score, PSA levels, and clinical stage.  

Types of Radical Prostatectomy at Sterling Hospitals Rajkot,  :  

• Open radical prostatectomy: This is the traditional approach where a long incision is made in the lower abdomen to access and remove the prostate gland. It allows for a comprehensive removal of the prostate and nearby lymph nodes if necessary.  

• Laparoscopic radical prostatectomy: This is a minimally invasive approach where several small incisions are made in the abdomen to insert a laparoscope and other surgical instruments to remove the prostate gland. It offers smaller incisions, less blood loss, and quicker recovery compared to open surgery.  

• Robot-assisted radical prostatectomy: This is a type of laparoscopic surgery where a robotic system is used to assist the surgeon in performing the procedure with greater precision and control. It allows for enhanced visualization and maneuverability, resulting in faster recovery and less postoperative pain.  

Recovery after Radical Prostatectomy at Sterling Hospitals Rajkot,  :  

• Hospital stay: The length of hospital stay may vary depending on the type of surgery and individual patient factors, but it typically ranges from 1-3 days for minimally invasive approaches and slightly longer for open surgery.  

• Pain management: Pain medication will be provided to manage postoperative pain, and patients are encouraged to follow the prescribed pain management plan.  

• Catheterization: A urinary catheter may be placed to drain urine from the bladder after surgery. It is usually removed within a few days to weeks, depending on the individual's recovery progress.  

• Activity and diet: Patients are encouraged to gradually resume normal activities, including walking and light exercises, as guided by their surgical team. A healthy diet and adequate hydration are important for recovery.  

• Follow-up appointments: Regular follow-up appointments will be scheduled to monitor the recovery progress, assess urinary and sexual function, and monitor for any potential complications.  

• Rehabilitation: In some cases, patients may require pelvic floor exercises or other forms of rehabilitation to restore urinary continence and sexual function after surgery.  

It's important to note that recovery timelines may vary for each individual, and it's essential to follow the postoperative care instructions provided by the surgical team for optimal recovery after radical prostatectomy.

Chemotherapy  

Chemotherapy is a widely used treatment modality in the field of oncology, including uro-oncology, for the management of cancer. It involves the use of anti-cancer drugs that work to destroy or inhibit the growth of cancer cells. As a part of the Department of Uro-Oncology at Sterling Hospitals Rajkot,  , chemotherapy is administered by expert oncologists in a comprehensive and patient-centric manner.  

Indications for chemotherapy in uro-oncology may include:  

• Urothelial carcinoma: Chemotherapy may be indicated for the treatment of urothelial carcinoma, which is a type of cancer that can occur in the urinary bladder, ureters, or renal pelvis. It may be given before surgery (neoadjuvant chemotherapy) to shrink tumors, after surgery (adjuvant chemotherapy) to prevent recurrence, or as palliative treatment for advanced or metastatic disease.  

• Prostate cancer: Chemotherapy may be used in advanced or metastatic prostate cancer that has spread beyond the prostate gland and is resistant to hormonal therapy.  

• Testicular cancer: Chemotherapy may be indicated for the treatment of testicular cancer, which is a rare but highly treatable form of cancer that typically responds well to chemotherapy.  

Types of chemotherapy used in uro-oncology may include:  

• Systemic chemotherapy: This involves the administration of anti-cancer drugs through the bloodstream, which allows the drugs to reach cancer cells throughout the body. It may be given orally or intravenously and may be used alone or in combination with other treatments.  

• Intravesical chemotherapy: This involves the instillation of anti-cancer drugs directly into the bladder through a catheter. It is commonly used in the treatment of early-stage bladder cancer to reduce the risk of recurrence.  

Recovery after chemotherapy varies depending on the type and stage of cancer, as well as the specific drugs and treatment regimen used. It may involve managing side effects such as nausea, fatigue, hair loss, and changes in blood counts. Regular monitoring of blood counts and other relevant parameters, along with close communication with the healthcare team, is important during and after chemotherapy.  

The Department of Uro-Oncology at Sterling Hospitals Rajkot,   offers comprehensive chemotherapy services with a patient-centered approach. The oncologists and healthcare professionals work closely with patients to develop personalized treatment plans, manage side effects, and provide support throughout the treatment process. State-of-the-art facilities, advanced chemotherapy protocols, and a compassionate care approach are the pillars of the department's commitment to providing optimal care for uro-oncology patients. 

Nephrectomy  

Nephrectomy is a surgical procedure performed to remove a kidney, either partially or completely. It may be indicated for various reasons, including benign or malignant tumors, kidney damage, kidney donation, or other medical conditions. As a part of the Department of Uro-Oncology at Sterling Hospitals Rajkot,  , nephrectomy is a specialized surgical procedure performed by experienced urologists to treat kidney-related conditions.  

Indications for nephrectomy may include:  

• Renal cancer: Nephrectomy may be recommended for the treatment of renal cell carcinoma, which is the most common type of kidney cancer. It may involve removing the entire kidney (radical nephrectomy) or just the tumor and a portion of the kidney (partial nephrectomy) depending on the location and size of the tumor.  

• Benign kidney tumors: Nephrectomy may be performed to remove benign tumors such as angiomyolipomas or oncocytomas that cause symptoms, are growing in size, or are causing other complications.  

• Kidney damage: In cases of severe kidney damage or non-functioning kidney due to chronic kidney disease or other conditions, nephrectomy may be performed to remove the affected kidney.  

• Kidney donation: Nephrectomy may be done for living kidney donation, where a healthy individual donates one kidney for transplantation into a recipient with end-stage renal disease.  

Types of nephrectomy may include:  

• Radical nephrectomy: This involves the complete removal of the affected kidney along with the adjacent lymph nodes and surrounding tissues. It may be done for kidney cancer or other conditions that require removal of the entire kidney.  

• Partial nephrectomy: Also known as nephron-sparing surgery, this involves removing only the tumor and a portion of the kidney while preserving the healthy portion of the kidney. It is usually preferred for smaller tumors or when preserving kidney function is important.  

Recovery after nephrectomy depends on the type of surgery and the patient's overall health. It may involve a hospital stay of a few days, pain management, monitoring of kidney function, and gradual resumption of normal activities. In some cases, additional treatments such as chemotherapy or radiation therapy may be recommended after nephrectomy for cancer. Regular follow-up appointments and monitoring are essential for long-term management.  

The Department of Uro-Oncology at Sterling Hospitals Rajkot,   is equipped with state-of-the-art facilities and a multidisciplinary team of urologists, oncologists, and other healthcare professionals who work together to provide comprehensive care for patients requiring nephrectomy. Individualized treatment plans, meticulous surgical techniques, and personalized care are the hallmarks of the department, ensuring the best possible outcomes for patients undergoing nephrectomy or other uro-oncological procedures.  

Hormone therapy  

Hormone therapy, also known as hormonal therapy or endocrine therapy, is a treatment modality commonly used in the management of certain types of urological cancers, such as prostate cancer. Hormone therapy works by interfering with the production or action of certain hormones that promote the growth of cancer cells. It is typically used in hormone-sensitive cancers, where the growth and spread of cancer cells are dependent on hormones.  

Indications for Hormone Therapy in Urological Cancer:  

• Prostate Cancer: Hormone therapy is commonly used in the treatment of prostate cancer, which is a hormone-sensitive cancer. It may be used in various settings, including as neoadjuvant or adjuvant therapy before or after surgery, or as palliative treatment for advanced or metastatic prostate cancer. Hormone therapy is used to lower the levels of male hormones, such as testosterone, which can promote the growth of prostate cancer cells.  

Recovery after Hormone Therapy:  

The recovery after hormone therapy depends on the specific treatment and the patient's overall health. Hormone therapy may be used as a long-term treatment for advanced or metastatic prostate cancer, and side effects may vary depending on the duration of treatment. Common side effects of hormone therapy may include hot flashes, decreased sex drive, erectile dysfunction, fatigue, weight gain, and bone loss. Regular monitoring of treatment response, management of side effects, and close follow-up with the healthcare team are important aspects of the recovery process.  

The Department of Uro-Oncology at Sterling Hospitals Rajkot,   provides expert hormonal therapy services for urological cancers, including prostate cancer. The experienced oncologists and healthcare professionals work closely with patients to develop personalized treatment plans, monitor treatment response, manage side effects, and provide comprehensive care throughout the treatment journey. State-of-the-art facilities and advanced treatment protocols are available to ensure the best possible outcomes for urological cancer patients. 

Targeted therapy and immunotherapy  

Targeted therapy and immunotherapy are two emerging treatment modalities in the field of uro-oncology, which involves the use of specialized medications that specifically target cancer cells or boost the immune system to fight against cancer. These therapies offer promising results in the management of certain urological cancers, such as kidney cancer and bladder cancer.  

• Targeted Therapy:  

Targeted therapy involves the use of medications that specifically target cancer cells by blocking the signals that promote their growth and spread. These medications work by inhibiting specific proteins or pathways that are overexpressed or mutated in cancer cells, while sparing normal healthy cells. Targeted therapy can be used as a standalone treatment or in combination with other treatment modalities, such as surgery, radiation therapy, or chemotherapy.  

Indications for Targeted Therapy in Urological Cancer:  

• Kidney Cancer: Targeted therapy has revolutionized the treatment of advanced or metastatic kidney cancer. Medications such as tyrosine kinase inhibitors (TKIs), such as sunitinib, pazopanib, and axitinib, and immune checkpoint inhibitors, such as nivolumab and pembrolizumab, are commonly used in the treatment of advanced or metastatic renal cell carcinoma (RCC).  

• Bladder Cancer: Targeted therapy can also be used in the management of advanced or metastatic bladder cancer. Medications such as immune checkpoint inhibitors, including atezolizumab, pembrolizumab, and nivolumab, are approved for the treatment of advanced or metastatic bladder cancer that has progressed despite chemotherapy.  

• Immunotherapy:  

Immunotherapy is a type of cancer treatment that uses the body's immune system to recognize and attack cancer cells. Immunotherapy works by boosting the immune system's ability to recognize and destroy cancer cells, thus enhancing the body's natural defence mechanisms against cancer.  

Indications for Immunotherapy in Urological Cancer:  

• Kidney Cancer: Immunotherapy, specifically immune checkpoint inhibitors, such as nivolumab and pembrolizumab, have shown significant efficacy in the treatment of advanced or metastatic renal cell carcinoma (RCC) that has progressed despite targeted therapy or other treatments.  

• Bladder Cancer: Immune checkpoint inhibitors, including pembrolizumab and atezolizumab, have been approved for the treatment of advanced or metastatic bladder cancer that has progressed despite chemotherapy.  

Recovery after Targeted Therapy and Immunotherapy:  

The recovery after targeted therapy and immunotherapy depends on the specific treatment and the patient's overall health. These therapies are generally well-tolerated, but they may be associated with side effects, including fatigue, diarrhea, skin rash, nausea, and immune-related adverse events. Regular monitoring of treatment response, management of side effects, and close follow-up with the healthcare team are important aspects of the recovery process.  

The Department of Uro-Oncology at Sterling Hospitals Rajkot,   provides advanced targeted therapy and immunotherapy services for urological cancers, including kidney cancer and bladder cancer. The experienced oncologists and healthcare professionals work closely with patients to develop personalized treatment plans, monitor treatment response, manage side effects, and provide comprehensive care throughout the treatment journey. State-of-the-art facilities and cutting-edge treatment options are available to ensure the best possible outcomes for uro-oncology patients.  

Radiotherapy  

Radiotherapy, also known as radiation therapy, is a common treatment modality used in the management of urological cancers. It involves the use of high-energy rays to target and destroy cancer cells, either from an external source (external beam radiation therapy) or from a radioactive material implanted near the tumor (brachytherapy).  

Indications for Radiotherapy in Urological Cancer:  

• Prostate Cancer: Radiotherapy is commonly used in the treatment of prostate cancer, either as a primary treatment option for localized disease or as a post-surgery (radical prostatectomy) adjuvant or salvage treatment for recurrent or high-risk disease. It can be delivered as external beam radiation therapy or brachytherapy, depending on the stage and location of the tumor.  

• Bladder Cancer: Radiotherapy may be used as a primary treatment option for bladder cancer in certain cases where surgery is not feasible, or as a part of bladder preservation strategies along with chemotherapy (chemoradiation) for muscle-invasive disease. It can be delivered as external beam radiation therapy or brachytherapy, depending on the stage and location of the tumor.  

• Kidney Cancer: Radiotherapy is not commonly used as a primary treatment for kidney cancer, but it may be considered in certain cases, such as for palliation of pain or symptoms in advanced or metastatic disease, or as part of a multimodal treatment approach in combination with surgery or other systemic therapies.  

Types of Radiotherapy for Urological Cancer:  

• External Beam Radiation Therapy: In external beam radiation therapy, high-energy rays are generated from a machine outside the body and directed towards the tumor site. The radiation is carefully planned and delivered to minimize the exposure of healthy tissues and organs surrounding the tumor. It is typically delivered in multiple sessions (fractions) over several weeks.  

• Brachytherapy: Brachytherapy, also known as internal radiation therapy, involves the placement of radioactive material directly into or near the tumor. It can be delivered using different techniques, such as permanent seed implants or temporary catheter-based techniques. Brachytherapy allows for the delivery of high doses of radiation directly to the tumor while sparing nearby healthy tissues.  

Recovery after Radiotherapy:  

The recovery after radiotherapy depends on the type, dose, and duration of treatment, as well as the patient's overall health. Common side effects of radiotherapy may include fatigue, skin changes, urinary or bowel changes, and sexual dysfunction, which are typically temporary and resolve after treatment completion. Close monitoring, symptom management, and follow-up with the healthcare team are important aspects of the recovery process.  

The Department of Uro-Oncology at Sterling Hospitals Rajkot,   offers advanced radiotherapy services for urological cancers, including prostate cancer, bladder cancer, and kidney cancer. The experienced radiation oncologists work closely with other members of the multidisciplinary team to develop personalized treatment plans, deliver precise and targeted radiation therapy, manage side effects, and provide comprehensive care to patients throughout their treatment journey. State-of-the-art facilities, cutting-edge technology, and a patient-centric approach ensure the best possible outcomes for uro-oncology patients.